Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Snapshots: Exelixis oncolytic compounds discussed at ASCO annual meeting

June 5, 2009

Banyu presents Wee1 kinase inhibitors as oncolytic compounds

June 5, 2009

NCI initiates phase II clinical trial of Rigel's oral Syk inhibitor R-788 in multiple cancers

June 4, 2009

Clinical study points to oncolytic activity of PF-02341066 in ALK-dependent tumors

June 4, 2009

AstraZeneca and Merck & Co. collaborate on novel combination anticancer regimen

June 4, 2009

Wyeth presents novel Raf kinase B inhibitors for cancer treatment

June 4, 2009

Novel serine/threonine kinase inhibitors discovered by Schering-Plough for cancer treatment

June 4, 2009

CHMP recommends approval of Afinitor for patients with advanced kidney cancer

June 3, 2009

Pfizer discontinues phase III trial of sunitinib in advanced breast cancer

June 3, 2009

Sanofi-aventis and Exelixis sign agreements for XL-147, XL-765 and PI3K inhibitors

June 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...